Register Today
Advocating, Accelerating, and Amplifying Lung Cancer Discovery: Lung-MAP Advocacy Webinar
Thursday, August 3rd
3:00PM – 4:00PM ET
Virtual Webinar
The Lung-MAP Accrual Enhancement Committee (AEC) is pleased to host an upcoming public webinar titled, Advocating, Accelerating, and Amplifying Lung Cancer Discovery. The webinar will feature leading experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP is working to overcome, and opportunities for patient engagement in the process. Importantly, the webinar will feature a panel discussion among lung cancer advocates with their perspectives on these topics.
Lung-MAP is a cancer clinical trial designed to quickly and efficiently test new treatments for advanced non-small cell lung cancers – which make up about 85 percent of all lung cancer diagnoses in the United States. Lung-MAP is offered at hospitals and clinics all over the country, making it easier for lung cancer patients to participate and get access to investigational treatments to fight their cancer.
Click the link above to register and scroll through below for the event agenda. We will include time for attendee Q&A during the webinar.
Agenda
3:00PM – Welcome Remarks
- Ryan Hohman, Vice President – Public Affairs, Friends of Cancer Research
- Jennifer Newsome, MS, Project Manager, Translational Science, Foundation for the National Institutes of Health
Welcome and Lung-MAP Overview
- Dr. Karen Reckamp, Director, Division of Medical Oncology, Cedars-Sinai Medical Center, Lung-MAP Vice Chair – S2302 Pragmatica-Lung
3:05PM – Lung-MAP Today: Accelerating Lung Cancer Discovery
- Moderator: Judy Johnson, MBA, SWOG Lung Committee Patient Advocate, Member of AEC
Updates on Current Studies: S1900E & S2302 Pragmatica-Lung
- Dr. Sukhmani Padda, Director, Thoracic Medical Oncology, Cedars-Sinai Cancer Center – S1900E
- Mary Redman, Lead Statistician, Lung-MAP
Updates on New Studies: S1900G
- Mary Redman, Lead Statistician, Lung-MAP
Lung-MAP Opportunities and Challenges of Enrollment from a Clinician’s Perspective
- Dr. Jay Nayak, AnMed Health Cancer Center
3:30 PM – Panel: Amplifying Patient Voices
- Moderator: Ryan Hohman, Friends of Cancer Research
- Terri Conneran, KRAS Kickers
- Ivy Elkins, EGFR Resisters
- Dr. Upal Basu Roy, LUNGevity
3:58PM – Closing remarks
- Ryan Hohman, Vice President – Public Affairs, Friends of Cancer Research
Lung-MAP is a groundbreaking public-private partnership that includes the NCI and its National Clinical Trials Network (NCTN) including SWOG Cancer Research Network, Friends of Cancer Research, the Foundation for the National Institutes of Health (FNIH), Foundation Medicine, pharmaceutical companies which provided their drugs for the study, and several lung cancer advocacy organizations.
